Related Experiment Videos
Good publication practice for pharmaceutical companies.
Elizabeth Wager1, Elizabeth A Field, Leni Grossman
1Sideview, Princes Risborough, Buckinghamshire, UK. liz@sideview.demon.co.uk
Current Medical Research and Opinion
|June 20, 2003
Summary
Pharmaceutical companies should ethically publish clinical trial results. These Good Publication Practice (GPP) guidelines ensure responsible reporting and collaboration among stakeholders in medical publications.
Area of Science:
- Publication Ethics
- Pharmaceutical Industry
- Clinical Trials
Background:
- Pharmaceutical companies face scrutiny regarding the publication of clinical trial data.
- Ensuring ethical and responsible dissemination of research findings is crucial.
Purpose of the Study:
- To present the first Good Publication Practice (GPP) guidelines developed specifically for the pharmaceutical industry.
- To promote responsible and ethical publication of sponsored clinical trial results.
Main Methods:
- Development of comprehensive guidelines for pharmaceutical companies.
- Inclusion of key areas: publication responsibility, investigator relations, preventing redundant publications, trial identification, and medical writer roles.
Main Results:
- The guidelines address the responsibility to publish all study results.
- They provide recommendations on managing investigator relationships and preventing publication misconduct.
- Methods for enhancing trial identification and the role of medical writers are outlined.
Conclusions:
- The GPP guidelines aim to foster discussion and provide a framework for ethical publication in the pharmaceutical sector.
- Endorsement and implementation of these guidelines are encouraged for all parties involved in sponsored clinical trial publications.